undamentalytics Newsletter
Sign in

Encompass Health Corp cash flow statement

In fiscal 2025, Encompass Health Corp's operations generated $1.18bn of cash; it spent $736m on capital projects, leaving free cash flow of $439m. It returned $71.1m in dividends and $158m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations6406587626357057167068511,0031,1761,304
Depreciation and amortisation173184200219203220244274300328360
Stock-based pay27488611426292951485759
Capital spending178226255372393525565583643736847
Free cash flow463433508263312191141268360439457
Free cash flow after stock pay435385422149286162112217312383399
Dividends paid84921011091121129960637177
Share buybacks6638046600031158280

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ARDT vs EHCCYH vs EHCEHC vs MDEHC vs THC

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Encompass Health Corp's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Encompass Health Corp.